Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR | |
Zhang, BL; Gao, B; Dong, SH; Zhang, YQ; Wu, YJ | |
刊名 | REGULATORY TOXICOLOGY AND PHARMACOLOGY
![]() |
2011-06 | |
卷号 | 60期号:1页码:73-78 |
关键词 | Anti-tumor activity rhIFN alpha 2a-NGR Immunogenicity Antibodies Binding Neutralizing |
ISSN号 | 0273-2300 |
通讯作者 | Wu, YJ (reprint author), Lanzhou Univ, Dept Pharmacol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China. |
学科主题 | Legal Medicine; Pharmacology & Pharmacy; Toxicology |
收录类别 | SCIE ; PUBMED ; MEDLINE ; BIOSIS |
出版地 | SAN DIEGO |
语种 | 英语 |
WOS记录号 | WOS:000291376700006 |
内容类型 | 期刊论文 |
源URL | [http://ir.lzu.edu.cn/handle/262010/121487] ![]() |
专题 | 基础医学院_期刊论文 |
推荐引用方式 GB/T 7714 | Zhang, BL,Gao, B,Dong, SH,et al. Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR[J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY,2011,60(1):73-78. |
APA | Zhang, BL,Gao, B,Dong, SH,Zhang, YQ,&Wu, YJ.(2011).Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR.REGULATORY TOXICOLOGY AND PHARMACOLOGY,60(1),73-78. |
MLA | Zhang, BL,et al."Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR".REGULATORY TOXICOLOGY AND PHARMACOLOGY 60.1(2011):73-78. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论